Targeting the FRA1-dependent transcriptional nexus in high FOXA1-driven endocrine-resistant and metastatic breast cancer

被引：0
|
作者：
Liu, Chia Chia
Qin, Lanfang
De Angelis, Carmine
Nanda, Sarmistha
Pereira, Resel
Shea, Martin J.
Nardone, Agostina
Jeselsohn, Rinath
Cohen, Ofir
Wagle, Nikhil
Liu, Zhijie
Rimawi, Mothaffar F.
Osborne, C. Kent
Schiff, Rachel
Fu, Xiaoyong
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD1-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD1-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Qin, Lanfang
    De Angelis, Carmine
    Nanda, Sarmistha
    Shea, Martin
    Nardone, Agostina
    Jeselsohn, Rinath
    Cohen, Ofir
    Wagle, Nikhil
    Rimawi, Mothaffar
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2021, 81 (04)
  • [2] FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Nanda, Sarmistha
    Qin, Lanfang
    Cataldo, Maria L.
    Sethunath, Vidyalakshmi
    Mehravaran, Sepideh
    Gutierrez, Carolina
    Chamness, Gary C.
    Feng, Qin
    O'Malley, Bert W.
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Cohen, Ofir
    Wagle, Nikhil
    Nardonek, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (52) : 26823 - 26834
  • [3] High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Liu, Chia -Chia
    De Angelis, Carmine
    Shea, Martin J.
    Nanda, Sarmistha
    Qin, Lanfang
    Mitchell, Tamika
    Cataldo, Maria L.
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Giuliano, Mario
    Gutierrez, Carolina
    Gyorffy, Balazs
    Trivedi, Meghana, V
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CELL REPORTS, 2023, 42 (08):
  • [4] Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Veeraraghavan, Jamunarani
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, Ckent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [5] FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, X.
    Pereira, R.
    Zhao, D.
    Jung, S. Y.
    Jeselsohn, R.
    Creighton, C. J.
    Shea, M.
    Nardone, A.
    Angelis, C. D.
    Tsimelzon, A.
    Wang, T.
    Gutierrez, C.
    Huang, S.
    Edwards, D. P.
    Rimawi, M. F.
    Hilsenbeck, S. G.
    Brown, M.
    Chen, K.
    Osborne, C. K.
    Schiff, R.
    CANCER RESEARCH, 2017, 77
  • [6] Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Shea, Martin J.
    Mitchell, Tamika
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Gutierrez, Carolina
    Gyorffy, Balazs
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [7] THE ROLE OF AP-1 IN ENDOCRINE-RESISTANT BREAST CANCER
    Malorni, L.
    Giuliano, M.
    Migliaccio, I.
    Creighton, C.
    Lupien, M.
    Hilsenbeck, S.
    Fu, X.
    Trivedi, M.
    Osborne, C. K.
    Schiff, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 37 - 37
  • [8] Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer
    Huang, Rui
    Faratian, Dana
    Sims, Andrew H.
    Wilson, Danielle
    Thomas, Jeremy S.
    Harrison, David J.
    Langdon, Simon P.
    PLOS ONE, 2014, 9 (04):
  • [9] Hyperactive FOXA1 activates super-enhancer-engaged HIF2α/EPAS1 to promote endocrine-resistant metastatic ER-positive breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Shea, Martin J.
    Nanda, Sarmistha
    Feng, Qin
    Jeselsohn, Rinath
    O'Malley, Bert W.
    Brown, Myles
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2018, 78 (04)
  • [10] Detection of ESR1 mutations in matched primary and metastatic samples from endocrine-resistant lobular breast cancer patients
    Desmedt, C.
    Pingitore, J.
    Rothe, F.
    Rouas, G.
    Bertucci, F.
    Galant, C.
    Rotmensz, N.
    van den Eynden, G.
    Salgado, R.
    Larsimont, D.
    Pruneri, G.
    Sotiriou, C.
    CANCER RESEARCH, 2017, 77
12345